{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:49:04Z","timestamp":1794574144649,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007049","name":"Korea Institute of Ocean Science & Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biomaterials.2024.122888","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T09:13:23Z","timestamp":1728551603000},"page":"122888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["An innovative strategy harnessing self-activating CAR-NK cells to mitigate TGF-\u03b21-driven immune suppression"],"prefix":"10.1016","volume":"314","author":[{"given":"Seung hun","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-9908","authenticated-orcid":false,"given":"Young Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Na","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Min","family":"Yuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Yop","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2250-9134","authenticated-orcid":false,"given":"Minkoo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Suk","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Chul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6785-2345","authenticated-orcid":false,"given":"Ji Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-712X","authenticated-orcid":false,"given":"Yong Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song Cheol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-2983","authenticated-orcid":false,"given":"Mihue","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2024.122888_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.688377","article-title":"The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy","volume":"11","author":"Principe","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biomaterials.2024.122888_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"16","key":"10.1016\/j.biomaterials.2024.122888_bib3","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122888_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122888_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41416-019-0479-5","article-title":"Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features","volume":"121","author":"Karamitopoulou","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122888_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2024.122888_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fimmu.2020.00311","article-title":"NK cell function regulation by TGF-beta-induced epigenetic mechanisms","volume":"11","author":"Regis","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122888_bib8","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.3389\/fimmu.2019.02357","article-title":"Natural killer cells in myeloid malignancies: immune surveillance, NK cell dysfunction, and pharmacological opportunities to bolster the endogenous NK cells","volume":"10","author":"Carlsten","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biomaterials.2024.122888_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113648","article-title":"Natural killer cell dysfunction in hepatocellular carcinoma: pathogenesis and clinical implications","volume":"19","author":"Sung","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.biomaterials.2024.122888_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142116","article-title":"Targeting the alphav integrin\/TGF-beta axis improves natural killer cell function against glioblastoma stem cells","volume":"131","author":"Shaim","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122888_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.immuni.2006.03.016","article-title":"Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells","volume":"24","author":"Yu","year":"2006","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122888_bib12","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"415","key":"10.1016\/j.biomaterials.2024.122888_bib13","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci. Signal."},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122888_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9100132","article-title":"Regulation of mTOR, metabolic fitness, and effector functions by cytokines in natural killer cells","volume":"9","author":"Viel","year":"2017","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122888_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002044","article-title":"TGFbeta drives NK cell metabolic dysfunction in human metastatic breast cancer","volume":"9","author":"Slattery","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122888_bib16","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.4049\/jimmunol.1202693","article-title":"Neuroblastoma-derived TGF-beta1 modulates the chemokine receptor repertoire of human resting NK cells","volume":"190","author":"Castriconi","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2024.122888_bib17","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3389\/fimmu.2019.01354","article-title":"Progressive impairment of NK cell cytotoxic degranulation is associated with TGF-beta1 deregulation and disease progression in pancreatic cancer","volume":"10","author":"Jun","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122888_bib18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.gendis.2022.10.019","article-title":"The role of TGF-beta in the tumor microenvironment of pancreatic cancer","volume":"10","author":"Luo","year":"2023","journal-title":"Genes Dis"},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122888_bib19","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1158\/2326-6066.CIR-21-1052","article-title":"TGFbeta and CIS inhibition overcomes NK-cell suppression to restore antitumor immunity","volume":"10","author":"Souza-Fonseca-Guimaraes","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biomaterials.2024.122888_bib20","article-title":"Generation of knock-out primary and expanded human NK cells using Cas9 ribonucleoproteins","volume":"136","author":"Naeimi Kararoudi","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122888_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jcyt.2016.12.005","article-title":"Cord blood natural killer cells expressing a dominant negative TGF-beta receptor: implications for adoptive immunotherapy for glioblastoma","volume":"19","author":"Yvon","year":"2017","journal-title":"Cytotherapy"},{"issue":"14","key":"10.1016\/j.biomaterials.2024.122888_bib22","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1158\/1078-0432.CCR-18-3183","article-title":"Engineering the TGFbeta receptor to enhance the therapeutic potential of natural killer cells as an immunotherapy for neuroblastoma","volume":"25","author":"Burga","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122888_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050421","article-title":"Encapsulating TGF-beta1 inhibitory peptides P17 and P144 as a promising strategy to facilitate their dissolution and to improve their functionalization","volume":"12","author":"Hanafy","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2024.122888_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1043-4666(03)00101-7","article-title":"A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury","volume":"22","author":"Ezquerro","year":"2003","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122888_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/gtc.12216","article-title":"Definition of the transcription factor TdIF1 consensus-binding sequence through genomewide mapping of its binding sites","volume":"20","author":"Koiwai","year":"2015","journal-title":"Gene Cell."},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122888_bib26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80061-1","article-title":"Human Smad3 and Smad4 are sequence-specific transcription activators","volume":"1","author":"Zawel","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.biomaterials.2024.122888_bib27","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3389\/fimmu.2019.02873","article-title":"Efficient and robust NK-cell transduction with Baboon envelope pseudotyped lentivector","volume":"10","author":"Colamartino","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122888_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006130","article-title":"Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6","volume":"11","author":"Lee","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10.1016\/j.biomaterials.2024.122888_bib29","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2024.122888_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/F1B64CL7H8VJKEAF","article-title":"Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis","volume":"124","author":"Hassan","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"issue":"12 Pt 1","key":"10.1016\/j.biomaterials.2024.122888_bib31","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2024.122888_bib32","first-page":"482","article-title":"[Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics]","volume":"42","author":"Ruan","year":"2007","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122888_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122888_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40425-019-0586-0","article-title":"Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics","volume":"7","author":"Davda","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122888_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122888_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drudis.2018.10.002","article-title":"Peptide-based therapeutics: quality specifications, regulatory considerations, and prospects","volume":"24","author":"Rastogi","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.biomaterials.2024.122888_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020222","article-title":"2021 FDA TIDES (peptides and oligonucleotides) harvest","volume":"15","author":"Al Shaer","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.biomaterials.2024.122888_bib38","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.biomaterials.2024.122888_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2024.122888_bib40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12935-022-02599-7","article-title":"Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures","volume":"22","author":"Feng","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biomaterials.2024.122888_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116791","article-title":"Cancer-associated fibroblast regulate proliferation and migration of prostate cancer cells through TGF-beta signaling pathway","volume":"235","author":"Sun","year":"2019","journal-title":"Life Sci."},{"issue":"13","key":"10.1016\/j.biomaterials.2024.122888_bib42","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/onc.2016.353","article-title":"Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells","volume":"36","author":"Richards","year":"2017","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.biomaterials.2024.122888_bib43","doi-asserted-by":"crossref","first-page":"20741","DOI":"10.18632\/oncotarget.15119","article-title":"IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2\/STAT3 signaling pathway","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2024.122888_bib44","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.semcancer.2021.03.006","article-title":"Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment","volume":"82","author":"Boyd","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.biomaterials.2024.122888_bib45","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/bjc.2013.768","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling","volume":"110","author":"Yu","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"5659","key":"10.1016\/j.biomaterials.2024.122888_bib46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","article-title":"TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia","volume":"303","author":"Bhowmick","year":"2004","journal-title":"Science"},{"issue":"Suppl 3","key":"10.1016\/j.biomaterials.2024.122888_bib47","doi-asserted-by":"crossref","first-page":"S1587","DOI":"10.1245\/s10434-015-4804-9","article-title":"TGF Beta1 expression correlates with survival and tumor aggressiveness of prostate cancer","volume":"22","author":"Wu","year":"2015","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.biomaterials.2024.122888_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.omto.2023.100730","article-title":"A novel GPI-anchored dominant-negative TGF-beta receptor II renders T cells unresponsive to TGF-beta signaling","volume":"31","author":"Petersen","year":"2023","journal-title":"Mol Ther Oncolytics"},{"issue":"4","key":"10.1016\/j.biomaterials.2024.122888_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133977","article-title":"TGF-beta inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors","volume":"5","author":"Tang","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.biomaterials.2024.122888_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF-beta signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224004228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961224004228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T17:15:45Z","timestamp":1730913345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961224004228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":50,"alternative-id":["S0142961224004228"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122888","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An innovative strategy harnessing self-activating CAR-NK cells to mitigate TGF-\u03b21-driven immune suppression","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"122888"}}